|Last Price$83.67||Day Change (%)-1.27%|
|Open Price$84.33||Day Change ($)-1.08|
|Day Range83.29–84.73||52-Week Range64.64–86.64|
As of Tue 01/27/2015 04:45 PM EST | USD
Express Scripts to Present at the J.P. Morgan Healthcare Conference
UPDATE: Major U.S. benchmarks challenge last-ditch support
Gilead, CVS strike deal on Hepatitis C drugs
The wide-moat pharmacy benefit manager is still undervalued.
Pharmacy benefits manager Express Scripts is attractively priced given its ability to fend off competitors for years to come.
The wide-moat pharmacy benefit manager--which is currently rated 4 stars by Morningstar--was Berkshire's only new money purchase during the third quarter.
Drug Prices to Get More Expensive -- Corporate Outlook
Merck's reinvigorated pipeline and Sanofi's minimal patent-loss exposure placed them atop our rankings this year, while GlaxoSmithKline joined Pfizer toward the bottom.
UPDATE: Eight charts plot the year in finance